Enhancer reprogramming underlies therapeutic utility of a SMARCA2 degrader in SMARCA4 mutant cancer
增强子重编程是SMARCA2降解剂在SMARCA4突变癌症中发挥治疗作用的基础。
期刊:Cell Chemical Biology
影响因子:6.6
doi:10.1016/j.chembiol.2024.09.004
Sasikumar Kotagiri ,Nicholas Blazanin ,Yuanxin Xi ,Yanyan Han ,Md Qudratullah ,Xiaobing Liang ,Yawen Wang ,Poonam Pandey ,Hira Mazhar ,Truong Nguyen Lam ,Anand Kamal Singh ,Jing Wang ,Yonathan Lissanu